Combination of nivolumab (nivo) plus ipilimumab (ipi) in the treatment of patients (pts) with deficient DNA mismatch repair (dMMR)/high microsatellite instability (MSI-H) metastatic colorectal cancer (mCRC): CheckMate 142 study.

被引：22

作者：

Andre, Thierry

Lonardi, Sara

Wong, Ka Yeung Mark

Morse, Michael

McDermott, Raymond S.

Hill, Andrew Graham

Hendlisz, Alain

Lenz, Heinz-Josef

Leach, Joseph W.

Moss, Rebecca Anne

Cao, Z. Alexander

Ledeine, Jean-Marie

Chan, Emily

Kopetz, Scott

Michael, J.

机构：

来源：

关键词：

D O I：

10.1200/JCO.2017.35.15_suppl.3531

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3531

引用

页数：5